BIOFILCHEM

Biofil Chemicals & Pharmaceuticals Share PriceBiofil Chemicals & Pharmaceuticals

₹52.3
-0.65 (-1.23%)
As on 06 December, 2023 | 00:55 BSE: 524396 NSE: BIOFILCHEMISIN: INE829A01014

Biofil Chemicals & Pharmaceuticals Performance

Day Range

  • Low 51.60
  • High 53.05
₹ 52.3

52 Week Range

  • Low 39.30
  • High 65.00
₹ 52.3
  • Open Price52.05
  • Previous Close52.95
  • Volume35060

Start SIP in Biofil Chemicals & Pharmaceuticals

Start SIP

Biofil Chemicals & Pharmaceuticals Share Price

  • Over 1 Month 6.84%
  • Over 3 Month 5.13%
  • Over 6 Month 18.19%
  • Over 1 Year -6.94%

Biofil Chemicals & Pharmaceuticals Key Statistics

P/E Ratio 125.9
PEG Ratio 6.3
Market Cap Cr 85
Price to Book Ratio 4.9
EPS 0.3
Dividend 0
Relative Strength Index 59.07
Money Flow Index 75.73
MACD Signal 0.7
Average True Range 2.31

Biofil Chemicals & Pharmaceuticals Investment Rating

  • Master Rating:
  • Biofil Chemicals & Pharmaceuticals has an operating revenue of Rs. 34.91 Cr. on a trailing 12-month basis. An annual revenue growth of 34% is outstanding, Pre-tax margin of 3% needs improvement, ROE of 3% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 6% and 14% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 63 which is a FAIR score but needs to improve its earnings, a RS Rating of 36 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 131 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Biofil Chemicals & Pharmaceuticals Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 1721413122
Operating Expenses Qtr Cr 1721312122
Operating Profit Qtr Cr 0000000
Depreciation Qtr Cr 0000000
Interest Qtr Cr 0000000
Tax Qtr Cr 0000000
Net Profit Qtr Cr 0000000
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 3023
Operating Expenses Annual Cr 2921
Operating Profit Annual in Cr 11
Depreciation Cr 00
Interest Annual Cr 00
Tax Annual Cr 00
Net Profit Annual Cr 11
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 0
Cash from Investing Activity Annual Cr 0
Cash from Financing Annual Activity Cr 0
Net Cash Flow Annual Cr 0
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 1717
Fixed Assets Annual Cr 99
Total Non Current Assets Annual Cr 99
Total Current Assets Annual Cr 229
Total Assets Annual Cr 3119
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 1110
ROE Annual % 34
ROCE Annual % 56
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 47
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Biofil Chemicals & Pharmaceuticals Technicals

EMA & SMA

Current Price
₹52.3
-0.65 (-1.23%)
pointer
  • Bullish Moving Average
  • ___
  • 14
  • Bearish Moving Average
  • ___
  • 2
  • 20 Day
  • ₹50.90
  • 50 Day
  • ₹49.76
  • 100 Day
  • ₹48.76
  • 200 Day
  • ₹48.65
  • 20 Day
  • ₹50.29
  • 50 Day
  • ₹49.69
  • 100 Day
  • ₹48.43
  • 200 Day
  • ₹46.40

Biofil Chemicals & Pharmaceuticals Resistance and Support

PIVOT
₹52.32
Resistance
First Resistance 53.03
Second Resistance 53.77
Third Resistance 54.48
RSI 59.07
MFI 75.73
MACD Single Line 0.70
MACD 1.09
Support
First Resistance 51.58
Second Resistance 50.87
Third Resistance 50.13

Biofil Chemicals & Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 39,641 2,610,360 65.85
Week 101,079 5,796,858 57.35
1 Month 59,150 3,505,232 59.26
6 Month 57,311 3,124,021 54.51

Biofil Chemicals & Pharmaceuticals Result Highlights

Biofil Chemicals & Pharmaceuticals Synopsis

NSE-Medical-Ethical Drugs

Biofil Chemicals belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 30.04 Cr. and Equity Capital is Rs. 16.27 Cr. for the Year ended 31/03/2023. Biofil Chemicals & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 04/01/1985 and has its registered office in the State of Madhya Pradesh, India. Company’s Corporate Identification Number(CIN) is L24233MP1985PLC002709 and registration number is 002709.
Market Cap 85
Sales 35
Shares in Float 0.86
No of funds 4
Yield
Book Value 4.92
U/D Vol ratio 1
LTDebt / Equity
Alpha 0.01
Beta 0.31

Biofil Chemicals & Pharmaceuticals

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 46.82%46.82%46.82%46.82%
Foreign Portfolio Investors
Financial Institutions/ Banks 0.04%0.04%0.04%0.04%
Individual Investors 37.97%38.1%38.14%38.04%
Others 15.17%15.04%15%15.1%

Biofil Chemicals & Pharmaceuticals Management

Name Designation
Mr. Ramesh Shah Managing Director
Mr. Ketan Shah Whole Time Director
Mr. Romil Shah Non Executive Director
Mrs. Shaila Jain Independent Director
Mr. Satish Beohar Independent Director
Mr. Ashok Kumar Ramawat Independent Director

Biofil Chemicals & Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Biofil Chemicals & Pharmaceuticals Corporate Action

Date Purpose Remarks
2023-11-09 Quarterly Results
2023-08-14 Quarterly Results
2023-05-30 Audited Results
2023-02-14 Quarterly Results
2022-11-14 Quarterly Results

Biofil Chemicals & Pharmaceuticals FAQs

What is Share Price of Biofil Chemicals & Pharmaceuticals ?

Biofil Chemicals & Pharmaceuticals share price is ₹52 As on 06 December, 2023 | 00:41

What is the Market Cap of Biofil Chemicals & Pharmaceuticals ?

The Market Cap of Biofil Chemicals & Pharmaceuticals is ₹85.1 Cr As on 06 December, 2023 | 00:41

What is the P/E ratio of Biofil Chemicals & Pharmaceuticals ?

The P/E ratio of Biofil Chemicals & Pharmaceuticals is 125.9 As on 06 December, 2023 | 00:41

What is the PB ratio of Biofil Chemicals & Pharmaceuticals ?

The PB ratio of Biofil Chemicals & Pharmaceuticals is 4.9 As on 06 December, 2023 | 00:41

Q2FY23